Alvotech (ALVO)
USD 8.12
(-2.4%)
USD 8.12
(-2.4%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.02 Billion USD | 31.76% |
| 2022 | 780.02 Million USD | 52.06% |
| 2021 | 512.98 Million USD | -23.31% |
| 2020 | 668.87 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 56.87 Million USD | -93.95% |
| 2024 Q1 | 940.59 Million USD | 2.0% |
| 2023 Q2 | 873.59 Million USD | 8.18% |
| 2023 FY | 1.02 Billion USD | 31.76% |
| 2023 Q4 | 1.02 Billion USD | 3.52% |
| 2023 Q3 | 992.85 Million USD | 13.65% |
| 2023 Q1 | 807.52 Million USD | 3.53% |
| 2022 Q1 | 186.16 Million USD | -63.71% |
| 2022 FY | 780.02 Million USD | 52.06% |
| 2022 Q4 | 780.02 Million USD | 40.87% |
| 2022 Q3 | 553.73 Million USD | 0.04% |
| 2022 Q2 | 553.49 Million USD | 197.31% |
| 2021 Q3 | 99.53 Million USD | 0.0% |
| 2021 Q4 | 512.98 Million USD | 415.38% |
| 2021 Q2 | 99.53 Million USD | 0.0% |
| 2021 Q1 | 99.53 Million USD | -29.58% |
| 2021 FY | 512.98 Million USD | -23.31% |
| 2020 Q2 | 141.34 Million USD | 0.0% |
| 2020 Q1 | 141.34 Million USD | 0.0% |
| 2020 Q4 | 141.34 Million USD | 0.0% |
| 2020 Q3 | 141.34 Million USD | 0.0% |
| 2020 FY | 668.87 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | -231.892% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -1028.471% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | -109.764% |
| Dynavax Technologies Corporation | 252.41 Million USD | -307.168% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | -104.92% |
| Cosmos Health Inc. | 3.03 Million USD | -33759.985% |
| Pacira BioSciences, Inc. | 513.79 Million USD | -100.034% |
| PainReform Ltd. | 30 Thousand USD | -3425786.667% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -190567.767% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -190567.767% |
| SCYNEXIS, Inc. | 12.15 Million USD | -8352.718% |
| Safety Shot Inc | 304.9 Thousand USD | -336975.239% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -877365.017% |
| Alpha Teknova, Inc. | 13.25 Million USD | -7656.139% |
| Embecta Corp. | 1.62 Billion USD | 36.768% |
| Bright Green Corporation | 201.78 Thousand USD | -509242.214% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -7612.487% |
| Journey Medical Corporation | 14.62 Million USD | -6928.902% |
| Procaps Group, S.A. | 28.41 Million USD | -3517.621% |
| Theratechnologies Inc. | 51.26 Million USD | -1904.967% |
| Harrow Health, Inc. | 183.17 Million USD | -461.093% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -1181240.23% |
| Biofrontera Inc. | 804 Thousand USD | -127731.592% |
| DURECT Corporation | 2.7 Million USD | -37937.232% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -2996.054% |
| Cronos Group Inc. | 1.55 Million USD | -65824.695% |
| OptiNose, Inc. | 611 Thousand USD | -168110.475% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | -106.251% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -2906.043% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -225782.637% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -1591.935% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -7939.381% |
| Radius Health, Inc. | 339.66 Million USD | -202.582% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -9919.166% |
| Phibro Animal Health Corporation | 458.28 Million USD | -124.262% |
| Procaps Group S.A. | 28.41 Million USD | -3517.621% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -15634.323% |
| Viatris Inc. | 16.18 Billion USD | 93.651% |
| Rockwell Medical, Inc. | 8.29 Million USD | -12293.176% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -9348.984% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -305790.932% |
| Tilray Brands, Inc. | 287.93 Million USD | -256.944% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -752.847% |
| Shineco, Inc. | 10.01 Million USD | -10159.878% |
| PetIQ, Inc. | 437.82 Million USD | -134.746% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -489312.381% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | -297.896% |
| Alimera Sciences, Inc. | 64.48 Million USD | -1493.707% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -2568.552% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -760706.579% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -14887.771% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -142645.278% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -4570999.448% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -3037.259% |
| Hempacco Co., Inc. | 5.93 Million USD | -17228.711% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 0.0% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -1728.245% |
| Lantheus Holdings, Inc. | 616.12 Million USD | -66.812% |
| Currenc Group, Inc. | 2.5 Million USD | -40896.277% |
| Kamada Ltd. | 7.43 Million USD | -13717.774% |
| Indivior PLC | 235.66 Million USD | -336.11% |
| Evoke Pharma, Inc. | 5 Million USD | -20455.32% |
| Flora Growth Corp. | 942 Thousand USD | -109004.671% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -4570999.448% |
| Evolus, Inc. | 120.35 Million USD | -753.917% |
| HUTCHMED (China) Limited | 48.18 Million USD | -2032.781% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | -74.434% |
| Akanda Corp. | 2.49 Million USD | -41057.477% |